Current Best Practices in Commercial Kit Evaluation and Validation for Biomarker Assays

Presented at the 10th Workshop on Recent Issues in Bioanalysis (WRIB), this presentation outlines the current best practices in commercial kit evaluation and validation for biomarker assays. Q2 Solutions has the breadth and depth of biomarker expertise, tools and capabilities to prepare and implement strategies to help drug developers effectively gain a competitive advantage in commercial kit evaluation – helping ensure your success in clinical trials, regulatory approvals and new product launches. 

Download this presentation to see how Q2 Solutions can be your partner of choice for any development program which requires identifying, designing and/or validating biomarkers, because we're able to go a step further to help you understand how these biomarkers can help deliver actionable insights for better health™.